XpresSpa Group Announces New Rapid Antigen Test on Select Delta Air Lines Flights to Italy from New York - John F. Kennedy In...
April 05 2021 - 8:30AM
XpresSpa Group Inc. (Nasdaq: XSPA), a health and wellness holding
company, today announced the addition of a new rapid antigen test
as part of an expanded COVID-19 testing line up. As part of this
pilot, XpresCheck has signed an agreement with Delta Air Lines to
administer this test to customers traveling from John F. Kennedy
International Airport to Milan Malpensa and Rome –Fiumicino
International Airports starting last week.
“This new single-use rapid antigen test is an
important addition to our line up, as it is more economical and
easy to administer, allowing us to test more passengers faster,”
said XpresSpa CEO Doug Satzman. “XpresCheck’s agreement with Delta
Air Lines to administer rapid antigen testing to customers
traveling from New York JFK’s XpresCheck’s Terminal 4 helps
increase traveler safety and restore confidence in airline travel
in a more efficient way at XpresCheck sites.”
The airline’s COVID-tested flights allow
customers eligible to travel to Italy to avoid the mandatory 14-day
quarantine on arrival, following a rigorous testing protocol before
and after travel. The flights to Milan will initially operate four
times per week beginning April 1 before moving to five times per
week on April 12 and daily in May. Flights to Rome will operate
three times per week in April and May, before increasing to five
times per week starting May 25. The program gives customers the
reassurance to fly more safely while vaccination efforts against
COVID-19 roll out worldwide.
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 45 locations in 23
airports globally. Through its XpresTest, Inc. subsidiary, the
Company provides COVID-19 screening and testing under the
XpresCheck™ brand at eleven locations in nine airports: Boston
Logan International Airport (2), Denver International Airport,
Dulles International Airport, JFK International Airport, Newark
Liberty International Airport (2), Phoenix Sky Harbor International
Airport, Reagan National Airport, Salt Lake City International
Airport, and Seattle-Tacoma International Airport. To learn more
about XpresSpa Group, visit: www.XpresSpaGroup.com.
Twitter: @xprescheck and Instagram:
@realxprescheck
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. In particular, these statements include, without
limitation, statements about our expectations relating to our new
XpresCheck™ concept, being able to expand testing to other
communicable diseases as well as administer vaccinations for the
seasonal flu, our positioning to be part of the national rollout of
various COVID-19 vaccinations, the degree to which our public
testing model assists passengers meet testing requirements in
select states and countries, our ability to identify and gain
access to the latest and best COVID-19 testing methodologies and
equipment, and our overall ability to manage the regulatory
challenges associated with this business line. Forward-looking
statements relating to expectations about future results or events
are based upon information available to XpresSpa Group as of
today's date and are not guarantees of the future performance of
the company, and actual results may vary materially from the
results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie FergusonJulie@jfprmedia.com(312)
385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024